GSK, India's Biological E Form JV To Develop Pediatric Vaccines
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline and India's Biological E have agreed to form a joint venture for research and development of a novel pediatric vaccine covering six infectious diseases common to developing nations.